Appraisal of transarterial immunoembolization for hepatocellular carcinoma: A clinicopathologic study

Journal of Clinical Gastroenterology

Volumn 32, Issue 1, 2001, Pages 59-65

  Yoshida, T ^a   Sakon, M ^a   Umeshita, K ^a   Kanai, T ^a   Miyamoto, A ^a   Takeda, T ^a   Gotoh, M ^a   Nakamura, H ^a   Wakasa, K ^a   Monden, M ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Fibrinogen; Hepatocellular carcinoma; OK 432; Postoperative recurrence; Preoperative treatment; Transarterial immunoembolization

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; EPIRUBICIN; FIBRINOGEN; GELATIN SPONGE; IODINATED POPPYSEED OIL; PICIBANIL; THROMBIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; METASTASIS; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETERIZATION; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; FEMALE; FIBRINOGEN; HEPATECTOMY; HEPATIC ARTERY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PICIBANIL; PREOPERATIVE CARE; PROGNOSIS; THROMBIN; TIME FACTORS;

EID: 0035166623     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200101000-00014     Document Type: Article

References (32)

1. Patterns of intrahepatic recurrence after curative resection of hepatocellular carcinoma
2. Prognostic factors after hepatocellular carcinomas
3. Long-term result of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathologic features
4. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma
5. Resection of hepatocellular carcinoma after embolization: Reevaluation of the advantages and disadvantages of preoperative embolization
6. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: A retrospective comparison of 138 liver resections
7. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal
8. Evaluation of preoperative transcatheter arterial embolization in the treatment of resectable primary liver cancer
9. Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study
10. Transcatheter embolization of hepatocellular carcinoma: Assessment of efficacy in a case of resection following embolization
11. An appraisal of transcatheter arterial embolization (TAIE) combined with transcatheter arterial infusion (TAI) of chemotherapeutic agent for hepatic malignancies
12. Limitation of transcatheter arterial chemoembolization using iodized oil for small hepatocellular carcinoma
13. Effect of transcatheter arterial embolization on the boundary architecture of hepatocellular carcinoma
14. New development of transarterial immunoembolization (TIE) for therapy of hepatocellutar carcinoma with intrahepatic metastases
15. Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon alpha 2, and OK-432
16. Cytotoxic and cytostatic effects of the Streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells
17. Augmentation of interleukin 1 and interleukin 2 production by OK-432
18. Antitumor therapy by induction of endogenous TNF
19. Production of interleukin 6 by human spleen cells stimulated with streptococcal preparation OK-432
20. Use of a rapid microwave fixation technique for immunocytochemical demonstration of tumor necrosis factor, interleukin-1α, and interleukin-1β in activated human peripheral mononuclear cells
21. Transcatheter oily chemoembolization of hepatocellular carcinoma
22. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas
23. Hepatocellular carcinoma after transcatheter hepatic arterial embolization
24. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: Antitumor effect and influence on normal tissue
25. Use of fibrinogen to enhance the antitumor effect of OK-432. A new approach to immunotherapy for colorectal carcinoma
26. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
27. Antitumor effect of human necrosis factor on human hepatoma cells PLC/PRF/5
28. Recombinant human interleukin 1 alpha is cytotoxic for and increases surface expression of HLA-A,B,C antigens of a human hepatoma cell line PLC/PRF/5
29. Lysis of fresh tumor cells by autologous peripheral blood and pleural effusion lymphocytes activated by OK-432
30. Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK-432: Enhanced generation of soluble cytotoxic factors
31. Establishment of cytotoxic CD4+ T cell clones from cancer patients treated by local immunotherapy
32. Hemodynamic effects of a large dose injection of OK-432